MEMENTO-VAScular COmponents of Dementia

NACompletedINTERVENTIONAL
Enrollment

332

Participants

Timeline

Start Date

November 4, 2014

Primary Completion Date

October 29, 2021

Study Completion Date

October 29, 2021

Conditions
Alzheimer's Disease (AD)Alzheimer's Disease (AD) Related Disorders
Interventions
OTHER

in Memento-VASCOD

"* Pulse wave velocity assessment~* Cerebral MRI including Arterial Spin Labeling (ASL) and Magnetic Resonance Angiography (MRA) sequences~* Ophthalmological exams: Spectral Domain-Optical Coherence Tomography (SD-OCT), colour photographs of the retina, visual acuity and axial lenght measurement~* Neuropsychological testing and behaviorial and mood scales~* Urinary albumin excretion measurement"

Trial Locations (10)

33000

CHU de Bordeaux - Pellegrin, Bordeaux

Unknown

CHU d'Amiens, Amiens

CHU de Dijon, Dijon

CHU de Lille, Lille

Hospices civils de Lyon, Lyon

AP-HM, Marseille

CHU de Montpellier, Montpellier

AP-HP - Hôpital BROCA, Paris

AP-HP - Hôpital LARIBOISIERE, Paris

CHU de Strasbourg, Strasbourg

All Listed Sponsors
collaborator

Ministry for Health and Solidarity, France

OTHER_GOV

lead

University Hospital, Bordeaux

OTHER

NCT02264899 - MEMENTO-VAScular COmponents of Dementia | Biotech Hunter | Biotech Hunter